|
|
|
| |
|
|
| |
The latest pulmonology news from News Medical |
|
|
|
 | | |  Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide significant benefits for cardiovascular, kidney, liver, joint, and sleep-related diseases. These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases. | | | | |  Radiation primes the immune system to attack lung tumors resistant to immunotherapy By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute. | |
|
|
| | | | |  Learn how early asthma diagnosis with FeNO testing can improve children’s health. | | | | |  FeNO guidelines vary worldwide—this article compares UK and international clinical practices. | | | | |  Understand the mechanisms behind biological drugs and how they help manage autoimmune conditions. | | | | |  While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for long-term control. | |
|
|
|
|
|
|
|
